ImmuPharma plc (AIM:IMM)
London
· Delayed Price · Currency is GBP · Price in GBX 6.65
-0.49 (-6.86%)
Mar 6, 2026, 4:33 PM GMT
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 35.89 million as of March 6, 2026. Its market cap has increased by 71.02% in one year.
Market Cap
35.89M
Enterprise Value
35.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.65
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 35.89M, a decrease of -0.61%. That is a compound annual growth rate of -0.03%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Poolbeg Pharma | 29.61M |
| Arecor Therapeutics | 27.18M |
| SkinBioTherapeutics | 24.78M |
| Aptamer Group | 22.92M |
| Ondine Biomedical | 53.25M |
| Sareum Holdings | 21.40M |
| hVIVO | 57.15M |
| Hemogenyx Pharmaceuticals | 60.33M |